Fiocruz
no Portal
neste Site
Fundação Oswaldo Cruz
Página Principal

Área de PDI em Doença de Chagas 2009

 doi
doi
Albuquerque-Cunha JM, Gonzalez MS, Garcia ES, Mello CB, Azambuja P, Almeida JC, de Souza W, Nogueira NF. Cytochemical characterization of microvillar and perimicrovillar membranes in the posterior midgut epithelium of Rhodnius prolixus. Arthropod Struct Dev. 2009 Jan; 38(1):31-44. Epub 2008 Jun 12.

Almeida CE, Folly-Ramos E, Peterson AT, Lima-Neiva V, Gumiel M, Duarte R, et al. Could the bug Triatoma sherlocki be vectoring Chagas disease in small mining communities in Bahia, Brazil? Medical and Veterinary Entomology. 2009 Dec;23(4):410-7. Med Vet Entomol

Almeida CE, Marcet PL, Gumiel M, Takiya DM, Cardozo-de-Almeida M, Pacheco RS, et al. Phylogenetic and phenotypic relationships among Triatoma carcavalloi (Hemiptera: Reduviidae: Triatominae) and related species collected in domiciles in Rio Grande do Sul State, Brazil. Journal of Vector Ecology . 2009 Dec;34(2):164-73. J of Vec Ecol 

 Scielo
Scielo
Alves-Ferreira M, Guimarăes A, Capriles P, Dardenne L, Degrave W. A new approach for potential drug target discovery through in silico metabolic pathway analysis using Trypanosoma cruzi genome information. Mem Inst Oswaldo Cruz. 2009 Dec;104(8):1100-10.

 Scielo
Scielo
Araújo A, Jansen A, Reinhard K, Ferreira L. Paleoparasitology of Chagas disease--a review. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:9-16.

Araújo CA, Waniek PJ, Jansen AM. An overview of Chagas disease and the role of triatomines on its distribution in Brazil. Vector Borne Zoonotic Dis. 2009 Jun;9(3):227-34. Vector Borne Zoonotic Dis 

 doi
doi
Bourguignon SC, Castro HC, Santos DO, Alves CR, Ferreira VF, Gama IL, et al. Trypanosoma cruzi: in vitro activity of Epoxy-alpha-Lap, a derivative of alpha-lapachone, on trypomastigote and amastigote forms. Experimental Parasitology. 2009 Jun;122(2):91-6.

 Scielo
Scielo
Britto C. Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:122-35.

 doi
doi
Calvet CM, Oliveira FOR, Araujo-Jorge TC, Pereira MCS. Regulation of extracellular matrix expression and distribution in Trypanosoma cruzi-infected cardiomyocytes. International Journal of Medical Microbiology. 2009 Apr;299(4):301-12.

Carvalho L, Abreu-Silva A, Hardoim DJ, Tedesco R, Mendes V, da Costa S, et al. Trypanosoma cruzi and myoid cells from seminiferous tubules: interaction and relation with fibrous components of extracellular matrix in experimental Chagas' disease. Int J Exp Pathol. 2009 Feb;90(1):52-7. Int J Exp Pathol 

 doi
doi
Castro DP, Figueiredo MB, Genta FA, Ribeiro IM, Tomassini TC, Azambuja P, Garcia ES. Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities. J Insect Physiol. 2009 Jun;55(6):532-7. Epub 2009 Feb 14.

 doi
doi
Cestari ID, Krarup A, Sim RB, Inal JM, Ramirez MI. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Molecular Immunology. 2009 Dec;47(2-3):426-37.

Correa-de-Santana E, Paez-Pereda M, Theodoropoulou M, Renner U, Stalla J, Stalla GK, et al. Modulation of Growth Hormone and Prolactin Secretion in Trypanosoma cruzi-Infected Mammosomatotrophic Cells. Neuroimmunomodulation. . 2009;16(3):208-12. Neuroimmunomodulation 

 Scielo
Scielo
Costa J, Lorenzo M. Biology, diversity and strategies for the monitoring and control of triatomines--Chagas disease vectors. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:46-51.

 doi
doi
Costa J, Peterson AT, Dujardin JP. Morphological evidence suggests homoploid hybridization as a possible mode of speciation in the Triatominae (Hemiptera, Heteroptera, Reduviidae). Infection Genetics and Evolution. 2009 Mar;9(2):263-70.

 Scielo
Scielo
Coura J. Present situation and new strategies for Chagas disease chemotherapy: a proposal. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):549-54.

 Scielo
Scielo
Coura JR, Dias JC. Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:31-40.

 Scielo
Scielo
Coutinho L, Ferreira MA, Cosson A, Batista MM, Batista DDJ, Minoprio P, et al. Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection. Memorias Do Instituto Oswaldo Cruz. 2009 Dec;104(8):1055-62.

 Scielo
Scielo
Daflon-Teixeira NF, Carvalho-Costa FA, Chiang RG, Lima MM. Influence of blood meal and mating in reproduction patterns of Triatoma brasiliensis females (Hemiptera: Reduviidae) under laboratory conditions. Memorias Do Instituto Oswaldo Cruz. 2009 Nov;104(7):1031-4.

Daliry A, Da Silva PB, Da Silva CF, Batista MM, De Castro SL, Tidwell RR, et al. In vitro analyses of the effect of aromatic diamidines upon Trypanosoma cruzi. Journal of Antimicrobial Chemotherapy. 2009 Oct;64(4):747-50. J. Antimicrob. Chemother

 doi
doi
de Alencar BC, Persechini PM, Haolla FA, de Oliveira G, Silverio JC, Lannes-Vieira J, Machado AV, Gazzinelli RT, Bruna-Romero O, Rodrigues MM. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun. 2009 Oct;77(10):4383-95. Epub 2009 Aug 3.

 Scielo
Scielo
de Lana M, Lopes LA, Martins HR, Bahia MT, Machado-de-Assis GF, Wendling AP, et al. Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment. Memorias Do Instituto Oswaldo Cruz. 2009 Dec;104(8):1139-47.

 doi
doi
de Meis J, Morrot A, Farias-de-Oliveira D, Villa-Verde D, Savino W. Differential regional immune response in Chagas disease. PLoS Negl Trop Dis. 2009;3(7):e417.

de Oliveira GM, da Silva TM, Batista WS, Franco M, Schor N. Acute Trypanosoma cruzi experimental infection induced renal ischemic/reperfusion lesion in mice. Parasitology Research. 2009 Dec;106(1):111-20. Parasitol Res

 Scielo
Scielo
de Oliveira GM, Masuda MO, Rocha NN, Schor N, Hooper CS, de Araujo-Jorge TC, et al. Absence of Fas-L aggravates renal injury in acute Trypanosoma cruzi infection. Memorias Do Instituto Oswaldo Cruz. 2009 Dec;104(8):1063-71.

 doi
doi
Dujardin JP, Costa J, Bustamante D, Jaramillo N, Catalá S. Deciphering morphology in Triatominae: the evolutionary signals. Acta Trop. 2009 May-Jun;110(2-3):101-11. Epub 2008 Nov 5. Review.

Durand JL, Mukherjee S, Commodari F, De Souza AP, Zhao D, Machado FS, Tanowitz HB, Jelicks LA. Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice. Am J Trop Med Hyg. 2009 May; 80(5):782-7. Am J Trop Med Hyg

 Scielo
Scielo
Escriba JM, Ponce E, Romero AD, Vinas PA, Marchiol A, Bassets G, et al. Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras. Memorias Do Instituto Oswaldo Cruz. 2009 Nov;104(7):986-91.

 Scielo
Scielo
Fe NF, Franca MS, Carvalho-Costa FA. Reassessing the entomological investigation around the first autochthonous case of Chagas disease in Western Brazilian Amazon. Memorias Do Instituto Oswaldo Cruz. . 2009 Feb;104(1):121-3.

Feder D, Gomes SAO, de Thomaz AA, Almeida DB, Faustino WM, Fontes A, et al. In vitro and in vivo documentation of quantum dots labeled Trypanosoma cruzi-Rhodnius prolixus interaction using confocal microscopy. Parasitology Research. 2009 Dec;106(1):85-93. Parasitol Res

 doi
doi
Garcia E, Castro D, Figueiredo M, Genta F, Azambuja P. Trypanosoma rangeli: a new perspective for studying the modulation of immune reactions of Rhodnius prolixus. Parasit Vectors. 2009;2(1):33.

Gaspar-Elsas MI, Queto T, Vasconcelos Z, Jones CP, Lannes-Vieira J, Xavier-Elsas P. Evidence for a regulatory role of alpha 4-integrins in the maturation of eosinophils generated from the bone marrow in the presence of dexamethasone. Clin Exp Allergy. 2009 Aug;39(8):1187-98. Epub 2009 Jun 8. Clin Exp Allergy

Gomes SAO, Misael D, Silva BA, Feder D, Silva CS, Goncalves TCM, et al. Major cysteine protease (cruzipain) in Z3 sylvatic isolates of Trypanosoma cruzi from Rio de Janeiro, Brazil. Parasitology Research . 2009 Sep;105(3):743-9. Parasitol Res

 Scielo
Scielo
Goncalves TCM, Freitas ALC, Freitas SPC. Surveillance of Chagas disease vectors in municipalities of the state of Ceara, Brazil. Memorias Do Instituto Oswaldo Cruz. 2009 Dec;104(8):1159-64.

 doi
doi
Guedes PMM, Veloso VM, Afonso LCC, Caliari MV, Carneiro CM, Diniz LF, et al. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Veterinary Immunology and Immunopathology. 2009 Jul;130(1-2):43-52.

 doi
doi
Haolla FA, Claser C, de Alencar BCG, Tzelepis F, de Vasconcelos JR, de Oliveira G, et al. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Vaccine. 2009 Sep;27(41):5644-53.

Henriques-Pons A, de Oliveira G. Is the Fas/Fas-L pathway a promising target for treating inflammatory heart disease? J Cardiovasc Pharmacol. 2009 Feb;53(2):94-9.J Cardiovasc Pharmacol

 Scielo
Scielo
Lannes-Vieira J, Silverio J, Pereira I, Vinagre N, Carvalho C, Paiva C, et al. Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors--how to make a dream come true. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:226-35.

 Scielo
Scielo
Lannes-Vieira J, Soeiro Mde N, Corrêa-Oliveira R, Araújo-Jorge TC. Chagas disease centennial anniversary celebration: historical overview and prospective proposals aiming to maintain vector control and improve patient prognosis--a permanent challenge. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:5-7.

 doi
doi
Lisboa CV, Xavier SCD, Herrera HM, Jansen AM. The ecology of the Trypanosoma cruzi transmission cycle: Dispersion of zymodeme 3 (Z3) in wild hosts from Brazilian biomes. Veterinary Parasitology. 2009 Oct;165(1-2):19-24.

 doi
doi
Marcili A, Valente VC, Valente SA, Junqueira ACV, da Silva FM, Pinto AYD, et al. Trypanosoma cruzi in Brazilian Amazonia: Lineages TCI and TCIIa in wild primates, Rhodnius spp. and in humans with Chagas disease associated with oral transmission. International Journal for Parasitology. 2009 Apr;39(5):615-23.

 doi
doi
Medeiros GA, Silverio JC, Marino A, Roffe E, Vieira V, Kroll-Palhares K, et al. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage. Microbes and Infection. 2009 Feb;11(2):264-73.

Mendonca VJ, da Silva MTA, de Araujo RF, Martins J, Bacci M, Almeida CE, et al. Phylogeny of Triatoma sherlocki (Hemiptera: Reduviidae: Triatominae) Inferred from Two Mitochondrial Genes Suggests Its Location Within the Triatoma brasiliensis Complex. American Journal of Tropical Medicine and Hygiene. 2009 Nov;81(5):858-64.Am J Trop Med Hyg

 doi
doi
Menna-Barreto RF, Salomão K, Dantas AP, Santa-Rita RM, Soares MJ, Barbosa HS, de Castro SL.. Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study. Micron. 2009 Feb;40(2):157-68. Epub 2008 Sep 4. Review.

Menna-Barreto RFS, Correa JR, Cascabulho CM, Fernandes MC, Pinto AV, Soares MJ, et al. Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi. Parasitology. 2009 Apr;136(5):499-510. Parasitol

 doi
doi
Menna-Barreto RFS, Goncalves RLS, Costa EM, Silva RSF, Pinto AV, Oliveira MF, et al. The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction. Free Radical Biology and Medicine. 2009 Sep;47(5):644-53.

 doi
doi
Noireau F, Diosque P, Jansen AM. Trypanosoma cruzi: adaptation to its vectors and its hosts. Vet Res. 2009 Mar-Apr;40(2):26. Epub 2009 Mar 3.

Oliveira TG, Carvalho-Costa FA, Sarquis O, Lima MM. Feeding and Defecation Patterns of Rhodnius nasutus (Hemiptera; Reduviidae), A Triatomine Native to an Area Endemic for Chagas Disease in the State of Ceara, Brazil. American Journal of Tropical Medicine and Hygiene. 2009 Oct;81(4):651-5. Am J Trop Med Hyg

 doi
doi
Pacheco M, da Silva CF, de Souza EM, Batista MM, da Silva PB, Kumar A, et al. Trypanosoma cruzi: Activity of heterocyclic cationic molecules in vitro. Experimental Parasitology. 2009 Sep;123(1):73-80.

Paiva CN, Figueiredo RT, Kroll-Palhares K, Silva AA, Silverio JC, Gibaldi D, et al. CCL2/MCP-1 controls parasite burden, cell infiltration, and mononuclear activation during acute Trypanosoma cruzi infection. Journal of Leukocyte Biology. 2009 Nov;86(5):1239-46. J Leukoc Biol

 doi
doi
Pinho RT, Beltramini LM, Alves CR, De-Simone SG. Trypanosoma cruzi: Isolation and characterization of aspartyl proteases. Experimental Parasitology. 2009 Jun;122(2):128-33.

 Pubmed
Pubmed
Pinto AV, de Castro SL. The trypanocidal activity of naphthoquinones: a review. Molecules. 2009 Nov 10;14(11):4570-90. Molecules

 doi
doi
Rademaker V, Herrera HM, Raffel TR, D'Andrea PS, Freitas TPT, Abreu UGP, et al. What is the role of small rodents in the transmission cycle of Trypanosoma cruzi and Trypanosoma evansi (Kinetoplastida Trypanosomatidae)? A study case in the Brazilian Pantanal. Acta Tropica. 2009 Aug;111(2):102-7.

Sodré C, Chapeaurouge A, Kalume D, de Mendonça Lima L, Perales J, Fernandes O. Proteomic map of Trypanosoma cruzi CL Brener: the reference strain of the genome project. Arch Microbiol. 2009 Feb;191(2):177-84. Arch Microbiol.

Soeiro M, de Castro S. Trypanosoma cruzi targets for new chemotherapeutic approaches. Expert Opin Ther Targets. 2009 Jan;13(1):105-21. Expert Opin Ther Targets.

 Scielo
Scielo
Soeiro Mde N, Dantas AP, Daliry A, Silva CF, Batista DG, de Souza EM, Oliveira GM, Salomão K, Batista MM, Pacheco MG, Silva PB, Santa-Rita RM, Barreto RF, Boykin DW, Castro SL. Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies. Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:301-10.

 doi
doi
Souza CF, Carneiro AB, Silveira AB, Laranja GAT, Silva-Neto MAC, da Costa SCG, et al. Heme-induced Trypanosoma cruzi proliferation is mediated by CaM kinase II. Biochemical and Biophysical Research Communications. 2009 Dec;390(3):541-6.

 doi
doi
Valente S, Valente VD, Pinto A, Cesar MDB, dos Santosb MP, Miranda COS, et al. Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2009 Mar;103(3):291-7.

Vannier-Santos M, De Castro S. Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill. Curr Drug Targets. 2009 Mar;10(3):246-60. Curr Drug Targets

 Scielo
Scielo
Waghabi MC, Coutinho-Silva R, Feige JJ, Higuchi MD, Becker D, Burnstock G, et al. Gap junction reduction in cardiomyocytes following transforming growth factor- beta treatment and Trypanosoma cruzi infection. Memorias Do Instituto Oswaldo Cruz. 2009 Dec;104(8):1083-90.

 doi
doi
Waghabi MC, de Souza EM, de Oliveira GM, Keramidas M, Feige JJ, Araujo-Jorge TC, et al. Pharmacological Inhibition of Transforming Growth Factor beta Signaling Decreases Infection and Prevents Heart Damage in Acute Chagas' Disease. Antimicrobial Agents and Chemotherapy. 2009 Nov;53(11):4694-701.

 doi
doi
Waniek PJ, Castro HC, Sathler PC, Miceli L, Jansen AM, Araujo CAC. Two novel defensin-encoding genes of the Chagas disease vector Triatoma brasiliensis (Reduviidae, Triatominae): Gene expression and peptide-structure modeling. Journal of Insect Physiology. 2009 Sep;55(9):840-8.

 doi
doi
Yun O, Lima MA, Ellman T, Chambi W, Castillo S, Flevaud L, et al. Feasibility, Drug Safety, and Effectiveness of Etiological Treatment Programs for Chagas Disease in Honduras, Guatemala, and Bolivia: 10-Year Experience of Medecins Sans Frontieres. Plos Neglected Tropical Diseases. 2009 Jul;3(7):8.

Instituto Oswaldo Cruz /IOC /FIOCRUZ - Av. Brasil, 4365 - Tel: (21) 2598-4220 | INTRANET IOC| EXPEDIENTE
Manguinhos - Rio de Janeiro - RJ - Brasil CEP: 21040-360

Logos